Jeonjinbio Statistics

Total Valuation

Jeonjinbio has a market cap or net worth of KRW 22.69 billion. The enterprise value is 16.97 billion.

Market Cap	22.69B
Enterprise Value	16.97B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 14.88% in one year.

Current Share Class	n/a
Shares Outstanding	9.06M
Shares Change (YoY)	+14.88%
Shares Change (QoQ)	+8.15%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	3.99%
Float	7.94M

Valuation Ratios

The trailing PE ratio is 21.01.

PE Ratio	21.01
Forward PE	n/a
PS Ratio	1.03
PB Ratio	1.30
P/TBV Ratio	1.30
P/FCF Ratio	10.33
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.30, with an EV/FCF ratio of 7.73.

EV / Earnings	17.36
EV / Sales	0.85
EV / EBITDA	6.30
EV / EBIT	15.05
EV / FCF	7.73

Financial Position

The company has a current ratio of 4.98, with a Debt / Equity ratio of 0.02.

Current Ratio	4.98
Quick Ratio	4.16
Debt / Equity	0.02
Debt / EBITDA	0.14
Debt / FCF	0.17
Interest Coverage	2.27

Financial Efficiency

Return on equity (ROE) is 7.57% and return on invested capital (ROIC) is 4.32%.

Return on Equity (ROE)	7.57%
Return on Assets (ROA)	3.74%
Return on Capital (ROIC)	4.32%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.06
Inventory Turnover	7.15

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.20% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-73.20%
50-Day Moving Average	2,401.68
200-Day Moving Average	4,324.67
Relative Strength Index (RSI)	50.88
Average Volume (20 Days)	40,833

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeonjinbio had revenue of KRW 19.96 billion and earned 977.67 million in profits. Earnings per share was 119.23.

Revenue	19.96B
Gross Profit	6.51B
Operating Income	1.13B
Pretax Income	977.67M
Net Income	977.67M
EBITDA	2.69B
EBIT	1.13B
Earnings Per Share (EPS)	119.23

Full Income Statement

Balance Sheet

The company has 6.09 billion in cash and 365.03 million in debt, giving a net cash position of 5.72 billion or 631.55 per share.

Cash & Cash Equivalents	6.09B
Total Debt	365.03M
Net Cash	5.72B
Net Cash Per Share	631.55
Equity (Book Value)	17.42B
Book Value Per Share	1,922.49
Working Capital	8.12B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.88 billion and capital expenditures -681.01 million, giving a free cash flow of 2.20 billion.

Operating Cash Flow	2.88B
Capital Expenditures	-681.01M
Free Cash Flow	2.20B
FCF Per Share	242.41

Full Cash Flow Statement

Margins

Gross margin is 32.61%, with operating and profit margins of 5.65% and 4.90%.

Gross Margin	32.61%
Operating Margin	5.65%
Pretax Margin	4.90%
Profit Margin	4.90%
EBITDA Margin	13.50%
EBIT Margin	5.65%
FCF Margin	11.00%

Dividends & Yields

Jeonjinbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-14.88%
Shareholder Yield	-14.88%
Earnings Yield	4.76%
FCF Yield	9.68%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeonjinbio has an Altman Z-Score of 12.85.

Altman Z-Score	12.85
Piotroski F-Score	n/a